Industry insights Effective Approaches, Successful Tech Transfer
01 Nov 2024 //
PRESS RELEASE
Softgel technology: A game-changer for oncology treatment
17 Oct 2024 //
PRESS RELEASE
Good as Gold: Douglas CDMO
15 Jul 2024 //
PRESS RELEASE
New Zealand Offers Streamlined Pharma Development Regulations
15 Jul 2024 //
PRESS RELEASE
Smart softgels: driving innovation in pharma
21 Jun 2024 //
PRESS RELEASE
CRO, CMO, and CDMO partnerships: A guide for pharma and biotech companies
05 Jun 2024 //
PRESS RELEASE
Bespoke client solutions: A personalized approach as a privately owned CDMO
16 May 2024 //
PRESS RELEASE
The case for softgels: Addressing stability, shelf-life, & bioavailability
26 Apr 2024 //
PRESS RELEASE
Softgels Address Stability, Shelf-Life, And Bioavailability In Drug Formulation
26 Apr 2024 //
PRESS RELEASE
Assessing quality of contract development & manufacturing organizations
18 Apr 2024 //
PRESS RELEASE
Evaluating CDMO Quality Beyond Standard Operating Procedures
14 Apr 2024 //
PRESS RELEASE
Douglas Pharmaceuticals secures US licensing deal to treat high grade cervical dysplasia
27 Sep 2023 //
PRESS RELEASE
Ketamine ER by Douglas Pharmaceuticals for Major Depressive Disorder: Likelihood of Approval
30 Aug 2023 //
PHARMACEUTICAL-TECHNOLOGY
Douglas Pharma’s Chief Scientific Officer talks about a new drug for treatment resistant depression
28 May 2023 //
PRESS RELEASE
Formation of Clinical Advisory Board for Lead Program R-107
17 Feb 2023 //
PRESS RELEASE
Douglas Announces Formation of Clinical Advisory Board for Lead Program R-107
26 Jan 2023 //
PR NEWSWIRE
Douglas Pharmaceuticals tackles treatment-resistant depression
22 Jan 2023 //
PRESS RELEASE
New Zealand’s largest medical R&D facility opens in West Auckland
15 Sep 2022 //
PRESS RELEASE
Clinicians China licenced to HTDK Pharmaceuticals
10 Apr 2022 //
PRESS RELEASE
Douglas announces positive top-line results from Phase 2 trial of R-107
16 Dec 2021 //
PRNEWSWIRE
Codiak BioSciences to Present at the Virtual William Blair Biotech Conference
07 Jul 2021 //
GLOBENEWSWIRE
Trial data suggests major breakthrough in Treatment Resistant Depression
17 Jun 2021 //
PRESS RELEASE
Douglas works with 75 year old inventor to create easy to us spray pump for those with arthritis
23 Apr 2020 //
PRESS RELEASE
Douglas wins Best Large Business in the New Zealand International Business Awards
11 Jul 2019 //
PRESS RELEASE
Douglas begins work on $35MM Research and Development building
24 Mar 2019 //
PRESS RELEASE
Douglas wins ‘Inspiring Team Leadership’ award
11 Sep 2018 //
PRESS RELEASE
New Zealand children to benefit from $9 million gift to Starship
08 Jun 2018 //
PRESS RELEASE
Douglas makes the Top 10 technology companies to watch in 2018 TIN Report
11 May 2018 //
PRESS RELEASE
Douglas signs new cancer drug R&D deal with Manchester University
31 Jan 2017 //
NBR
PharmaVentures` Latest Deal: Douglas Pharmaceuticals acquires Vital Foods` Phloe® product line in New Zealand
04 Sep 2015 //
PHARMAVENTURES